BBS-Bioactive Bone Substitutes Plc announced US Patent for the Manufacture of ARTEBONE® product, As announced in November 17 2021 release A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION, after the approval of the patent application for manufacturing claims of BBS-Bioactive Bone Substitutes Plc's, this patent has now been granted in the United States on January 11, 2022.
BBS-Bioactive Bone Substitutes Oyj
Equities
BONEH
FI4000260583
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.348 EUR | +1.75% |
|
+8.75% | -28.83% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.83% | 7.42M | |
+11.75% | 127B | |
+2.01% | 12.35B | |
-18.47% | 7.1B | |
+56.20% | 6.78B | |
+9.27% | 3.47B | |
-15.41% | 2.6B | |
-18.25% | 1.91B | |
-27.00% | 1.62B | |
-37.52% | 1.45B |
- Stock Market
- Equities
- BONEH Stock
- News BBS-Bioactive Bone Substitutes Oyj
- BBS-Bioactive Bone Substitutes Oyj Announces US Patent for the Manufacture of Artebone Product